Intelicanna Net Income vs. Market Capitalization

INTL Stock   56.00  1.80  3.11%   
Based on the key profitability measurements obtained from Intelicanna's financial statements, Intelicanna may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Intelicanna's ability to earn profits and add value for shareholders.
For Intelicanna profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Intelicanna to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Intelicanna utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Intelicanna's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Intelicanna over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Intelicanna's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intelicanna is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intelicanna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Intelicanna Market Capitalization vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Intelicanna's current stock value. Our valuation model uses many indicators to compare Intelicanna value to that of its competitors to determine the firm's financial worth.
Intelicanna is currently regarded as number one stock in net income category among its peers. It also is currently regarded as number one stock in market capitalization category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Intelicanna by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intelicanna's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Intelicanna Market Capitalization vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Intelicanna

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(14.64 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Intelicanna

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
17 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Intelicanna Market Capitalization vs Competition

Intelicanna is currently regarded as number one stock in market capitalization category among its peers. Market capitalization of Drug Manufacturers-Specialty & Generic industry is currently estimated at about 620.36 Million. Intelicanna holds roughly 17 Million in market capitalization claiming about 2.74% of equities under Drug Manufacturers-Specialty & Generic industry.
Capitalization  Total debt  Valuation  Revenue  Workforce

Intelicanna Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Intelicanna. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Intelicanna position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Intelicanna's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Intelicanna without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Use Investing Themes to Complement your Intelicanna position

In addition to having Intelicanna in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cryptocurrency ETFs Thematic Idea Now

Cryptocurrency ETFs
Cryptocurrency ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Cryptocurrency ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Intelicanna Stock

To fully project Intelicanna's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Intelicanna at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Intelicanna's income statement, its balance sheet, and the statement of cash flows.
Potential Intelicanna investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Intelicanna investors may work on each financial statement separately, they are all related. The changes in Intelicanna's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Intelicanna's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.